Abstract
The pro-inflammatory and pro-angiogenic chemokine interleukin-8 (IL-8, CXCL8) induces proliferation and invasion of solid tumor cells. In many types of solid cancer, including triple-negative breast cancer (TNBC), the IL-8 expression is induced by proteasome inhibition. In this chapter, we describe a protocol for the analysis of TNBC cell invasion induced by IL-8 in response to proteasome inhibition by bortezomib (BZ). Using this approach, we show that BZ increases the invasion ability of TNBC cells, and that the BZ-increased TNBC cell invasion is suppressed by IκB kinase (IKK) inhibition, which also decreases the IL-8 expression. The experimental protocol includes the cell invasion assay, microscopic evaluation of the invading cells, and quantitative analysis of the obtained images. This protocol should be applicable also for measurement of chemokine-induced tumor cell invasion in other types of cancer cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Waugh DJ, Wilson C (2008) The interleukin-8 pathway in cancer. Clin Cancer Res 14:6735–6741
Lazennec G, Richmond A (2010) Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol Med 16:133–144
Freund A, Chauveau C, Brouillet JP, Lucas A, Lacroix M, Licznar A et al (2003) IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells. Oncogene 22:256–265
Freund A, Jolivel V, Durand S, Kersual N, Chalbos D, Chavey C et al (2004) Mechanisms underlying differential expression of interleukin-8 in breast cancer cells. Oncogene 23:6105–6114
Rody A, Karn T, Liedtke C, Pusztai L, Ruckhaeberle E, Hanker L et al (2011) A clinically relevant gene signature in triple negative and basal-like breast cancer. Breast Cancer Res 13:R97
Hartman ZC, Poage GM, den Hollander P, Tsimelzon A, Hill J, Panupinthu N et al (2013) Growth of triple-negative breast cancer cells relies upon coordinate autocrine expression of the proinflammatory cytokines IL-6 and IL-8. Cancer Res 73:3470–3480
Hideshima T, Richardson P, Chauhan D, Palombella VJ, Elliott PJ, Adams J et al (2001) The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res 61:3071–3076
Richardson PG, Mitsiades C, Hideshima T, Anderson KC (2005) Proteasome inhibition in the treatment of cancer. Cell Cycle 4:290–296
Shah JJ, Orlowski RZ (2009) Proteasome inhibitors in the treatment of multiple myeloma. Leukemia 23:1964–1979
Kuhn DJ, Orlowski RZ (2012) The immunoproteasome as a target in hematologic malignancies. Semin Hematol 49:258–262
McConkey DJ, Zhu K (2008) Mechanisms of proteasome inhibitor action and resistance in cancer. Drug Resist Updat 11:164–179
Chen YJ, Yeh MH, Yu MC, Wei YL, Chen WS, Chen JY et al (2013) Lapatinib-induced NFκB activation sensitizes triple-negative breast cancer cells to proteasome inhibitors. Breast Cancer Res 15:R108
Petrocca F, Altschuler G, Tan SM, Mendillo ML, Yan H, Jerry DJ et al (2013) A genome-wide siRNA screen identifies proteasome addiction as a vulnerability of basal-like triple-negative breast cancer cells. Cancer Cell 24:182–196
Deshmukh RR, Kim S, Elghoul Y, Dou QP (2017) P-glycoprotein inhibition sensitizes human breast cancer cells to proteasome inhibitors. J Cell Biochem 118:1239–1248
Vu HY, Juvekar A, Ghosh C, Ramaswami S, Le DH, Vancurova I (2008) Proteasome inhibitors induce apoptosis of prostate cancer cells by inducing nuclear translocation of IκBα. Arch Biochem Biophys 475:156–163
Manna S, Singha B, Phyo SA, Gatla HR, Chang TP, Sanacora S et al (2013) Proteasome inhibition by bortezomib increases IL-8 expression in androgen-independent prostate cancer cells: the role of IKKα. J Immunol 191:2837–2846
Singha B, Gatla HR, Manna S, Chang TP, Sanacora S, Poltoratsky V et al (2014) Proteasome inhibition increases recruitment of IκB kinase β (IKKβ), S536P-p65, and transcription factor EGR1 to IL-8 promoter, resulting in increased IL-8 production in ovarian cancer cells. J Biol Chem 289:2687–2700
Uddin MM, Zou Y, Sharma T, Gatla HR, Vancurova I (2018) Proteasome inhibition induces IKK-dependent interleukin-8 expression in triple negative breast cancer cells: opportunity for combination therapy. PLoS One 13(8):e0201858. https://doi.org/10.1371/journal.pone.0201858
Acknowledgements
This work was supported by NIH grant CA202775 to I. Vancurova.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Uddin, M.M., Gaire, B., Deza, B., Vancurova, I. (2020). Interleukin-8-Induced Invasion Assay in Triple-Negative Breast Cancer Cells. In: Vancurova, I., Zhu, Y. (eds) Immune Mediators in Cancer. Methods in Molecular Biology, vol 2108. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0247-8_9
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0247-8_9
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0246-1
Online ISBN: 978-1-0716-0247-8
eBook Packages: Springer Protocols